title: In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression.
abstract: According to the rate of depletion of CD4 cell counts, we grouped 12 cases of human immunodeficiency virus type 1 (HIV-1) infection as 6 rapid (21.0 to 33.8 cells per microl per month) and 6 slow (0.9 to 7.9 cells per microl per month) progressors and determined the individual viral quasispecies patterns by sequencing the genome region encoding the V1, V2, and V3 loops of envelope protein. Although the quasispecies structures varied widely from one individual to another, a strong correlation was observed between a low rate of disease progression and a high degree of genetic diversity of HIV-1. Furthermore, the V2 loop extension was observed specifically in individuals with slow or no disease progression, whereas basic amino acid substitutions in V3 characteristic of a viral phenotype shift from non-syncytium inducing to syncytium inducing were observed in patients with advanced stages of disease regardless of their rate of disease progression. Studies with recombinant viruses suggested that elongation of V2 potentially restricts the capacity of HIV-1 to replicate in macrophages. Thus, our results suggest the association of distinct sequence features of both V3 and V2 with particular patterns of disease progression. Elongation of the V2 loop may be a good predictor of slow disease progression, while basic substitutions of V3 without elongation of V2 are characteristic of rapid progression.
authors.affiliation: Department of Viral Infection, University of Tokyo, and AIDS Research Center, Minato-ku, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Shioda
authors.forename: S
authors.initials: S
authors.lastname: Oka
authors.forename: X
authors.initials: X
authors.lastname: Xin
authors.forename: H
authors.initials: H
authors.lastname: Liu
authors.forename: R
authors.initials: R
authors.lastname: Harukuni
authors.forename: A
authors.initials: A
authors.lastname: Kurotani
authors.forename: M
authors.initials: M
authors.lastname: Fukushima
authors.forename: M K
authors.initials: MK
authors.lastname: Hasan
authors.forename: T
authors.initials: T
authors.lastname: Shiino
authors.forename: Y
authors.initials: Y
authors.lastname: Takebe
authors.forename: A
authors.initials: A
authors.lastname: Iwamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Nagai
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D002461:Cell Line, Transformed; D004279:DNA, Viral; D018450:Disease Progression; D019143:Evolution, Molecular; D014644:Genetic Variation; D015699:HIV Envelope Protein gp120 / Q000235:genetics*; D015658:HIV Infections / Q000097:blood / Q000503:physiopathology / Q000821:virology*; D015497:HIV-1 / Q000145:classification / Q000235:genetics* / Q000472:pathogenicity; D006801:Humans; D008969:Molecular Sequence Data; D010802:Phylogeny; D017386:Sequence Homology, Amino Acid; D014407:Tumor Cells, Cultured
chemical_list: D004279:DNA, Viral; D015699:HIV Envelope Protein gp120